Castle Biosciences, Inc. (CSTL)
38.91
-0.40
(-1.02%)
USD |
NASDAQ |
Dec 31, 16:00
38.91
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Cash from Investing (Quarterly): -18.39M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -6.163M |
| Delcath Systems, Inc. | -0.466M |
| Star Operating Cos., Inc. | -0.176M |
| CorMedix, Inc. | -291.32M |
| CytoSorbents Corp. | 0.055M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 22.63M |
| Cash from Financing (Quarterly) | -0.919M |
| Free Cash Flow | 32.06M |
| Free Cash Flow Per Share (Quarterly) | 0.2682 |
| Free Cash Flow to Equity (Quarterly) | 8.01M |
| Free Cash Flow to Firm (Quarterly) | 7.828M |
| Free Cash Flow Yield | 2.81% |